A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2011
10/20/2011	WO2011129371A1 GENE GROUP CAPABLE OF ENHANCING ANTI-TUMOR EFFECT OF 5-FU ALONE OR IFN-α/5-FU COMBINATION
10/20/2011	WO2011127625A1 Method for regulating microrna content in organisms and uses thereof
10/20/2011	WO2011072247A8 Pathogen restriction factors
10/20/2011	WO2011038210A3 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
10/20/2011	WO2011025862A3 Treatment of atp-binding cassette sub-family b member 1 (abcb1) related diseases by inhibition of natural antisense transcript to abcb1
10/20/2011	WO2010117829A8 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome
10/20/2011	US20110257384 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
10/20/2011	US20110256235 Compositions and methods relating to prevention of chemotherapy-induced alopecia
10/20/2011	US20110256217 Pulsatile release compositions and methods for enhanced intestinal drug absorption
10/20/2011	US20110256175 Amino lipids and methods for the delivery of nucleic acids
10/20/2011	US20110256114 T-cell receptor and nucleic acid encoding the receptor
10/20/2011	US20110256112 Compensating for Atrioventricular Block Using a Nucleic Acid Encoding a Sodium Channel or Gap Junction Protein
10/20/2011	US20110256104 Complexing agents for compositions containing inclusion complexes
10/19/2011	EP2377849A2 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient
10/19/2011	EP2377559A1 Targeting cells with altered microRNA expression
10/19/2011	EP2377558A2 Composition for improving inflammatory disease using abh antigens
10/19/2011	EP2377404A1 A dermal micro-organ which is an explant of living tissue
10/19/2011	EP2377403A1 A genetically modified dermal micro-organ expressing factor VIII
10/19/2011	EP2377402A1 A genetically modified dermal micro-organ expressing interferon
10/19/2011	EP2377401A1 A genetically modified dermal micro-organ expressing erythropoietin
10/19/2011	EP2375907A1 Treatment of diseases, disorders or conditions of the lung using placental cells
10/19/2011	EP2221377B1 Oligonucleotide compositions with enhanced efficiency
10/19/2011	EP1942945B1 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
10/19/2011	EP1899466B1 Sirna molecules for treatment of blood vessels
10/19/2011	EP1765414B1 Peptide conjugated, inosine-substituted antisense oligomer compound and method
10/19/2011	EP1762610B1 Truncated dance, dance complex and method of using these
10/19/2011	EP1513506B1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof
10/19/2011	EP1383793B1 Insulin and igf-1 receptor agonists and antagonists
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1225229B1 Gene transfer method
10/19/2011	EP1165132B1 Dry formulation for transcutaneous immunization
10/19/2011	CN1964627B Methods and compositions for treating neuropathies
10/19/2011	CN102224258A Methods for treating, diagnosing, and monitoring lupus
10/19/2011	CN102220423A Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/19/2011	CN102220376A Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
10/19/2011	CN102220357A Multivalent vaccines comprising recombinant viral vectors
10/19/2011	CN102220336A Tumour chemotherapy drug sensitive gene and application of same
10/19/2011	CN102220335A Guanine-rich nucleic acid aptamer and application thereof
10/19/2011	CN102220326A SiRNA of SjLGL gene of schistosoma japonica and use thereof
10/19/2011	CN102220324A SiRNA for inhibiting gene expression of caspase-3
10/19/2011	CN102220283A Multifunctional immune killing transgenic cell as well as preparation method and use thereof
10/19/2011	CN102219860A FGFR-Fc fusion protein and applications thereof
10/19/2011	CN102219859A Fusion protein for antagonizing angiogenesis inducible factor and application thereof
10/19/2011	CN102219858A Cryptosporidium parvum CTL multi-epitope gene and fusion protein and application thereof
10/19/2011	CN102219847A Defensin mNP-1 and applications thereof in preparing anti-influenza virus drugs
10/19/2011	CN102218148A Use of epstein-barr virus miR-BART1-5p antisense oligonucleotide in preparing drugs for treating nasopharyngeal carcinoma
10/19/2011	CN102218147A Use of epstein-barr virus miR-BART7 antisense oligonucleotide in preparing drugs for treating nasopharyngeal carcinoma
10/19/2011	CN102218146A ShRNA (Short Hairpin Ribonucleic Acid) kit for treating animal model suffered from alzheimer disease
10/19/2011	CN102218145A Medicinal composition for protecting optic nerve of glaucoma and preparation method thereof
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218139A Medicament for treating and/or preventing viral infection
10/19/2011	CN102218136A Anti-reovirus oral gene engineering vaccine and its preparation method
10/19/2011	CN101550189B Anthropogenic antivirulin glycosidoprotein neutralizing genetic engineering antibody RD9 and preparation and application thereof
10/18/2011	US8039609 Aptamers directed to MUC1
10/18/2011	US8039587 Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector
10/18/2011	US8039446 Compounds for the modulation of beta-catenin expression
10/18/2011	US8039445 Methods and devices for delivering a therapeutic product to the ocular sphere of a subject
10/18/2011	US8039444 Antisense permeation enhancers
10/18/2011	US8039443 polynucleotides that bind to proteins that regulate cell growth and division; used as antitumor agents alone or in combination with known cytotoxic agents
10/18/2011	US8039259 Buffer solution for electroporation and a method comprising the use of the same
10/18/2011	US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011	US8038995 Human N-type calcium channel isoform and uses thereof
10/18/2011	CA2232237C Reagents and methods useful for detecting diseases of the breast
10/18/2011	CA2228944C Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides
10/13/2011	WO2011127337A2 Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21
10/13/2011	WO2011127304A2 Methods of treating an overweight subject
10/13/2011	WO2011127190A1 Post-transcriptional regulation of rna-related processes using encoded protein-binding rna aptamers
10/13/2011	WO2011127174A1 Strains of xenotropic murine leukemia-related virus and methods for detection thereof
10/13/2011	WO2011126937A1 Targeted intracellular delivery of oligonucleotides via conjugation with small molecule ligands
10/13/2011	WO2011126842A2 Targeting micrornas for the treatment of cardiac disorders
10/13/2011	WO2011126808A2 Pharmacologically induced transgene ablation system
10/13/2011	WO2011126673A1 Cell reservoirs created by polymer plugs
10/13/2011	WO2011125943A1 Modified oligonucleotide
10/13/2011	WO2011125055A2 Synthetic constructs for polynucleotide and protein expression
10/13/2011	WO2011124899A1 Cell poration
10/13/2011	WO2011097420A3 Selection and characterization of dna aptamers with binding selectivity to campylobacter jejuni using whole-cell selex
10/13/2011	WO2011091304A9 Delivery system for diagnostic and therapeutic agents
10/13/2011	WO2011068546A3 Prognosis, diagnosis and identification of multiple myeloma based on global gene expression profiling
10/13/2011	WO2011012316A3 Rna with a combination of unmodified and modified nucleotides for protein expression
10/13/2011	WO2010103284A8 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene
10/13/2011	US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor
10/13/2011	US20110251265 Polyamine-containing polymers and methods of synthesis and use
10/13/2011	US20110251141 Composition for topical treatment of mixed vaginal infections
10/13/2011	US20110251122 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
10/13/2011	US20110250650 Lentiviral vectors for the preparation of immunotherapeutical compositions
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250234 Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof
10/13/2011	US20110250228 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
10/13/2011	US20110250192 Use of microrna signatures for assessing risk levels of neuroblastoma patients
10/13/2011	US20110250188 LCMV-GP-VSV-Pseudotyped Vectors and Tumor-Infiltrating Virus-Producing Cells for the Therapy of Tumors
10/13/2011	US20110250187 Compositions and methods for treating hypophosphatasia
10/13/2011	US20110250186 Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1
10/13/2011	US20110250168 Sialoadhesin-related compositions and methods
10/13/2011	CA2795498A1 Cell poration
10/13/2011	CA2795281A1 Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21
10/13/2011	CA2793633A1 Pharmacologically induced transgene ablation system
10/12/2011	EP2374889A2 Novel compounds
10/12/2011	EP2374885A2 ENA nucleic acid drugs modifying splicing in mRNA precursor
10/12/2011	EP2374884A2 Human miRNAs isolated from mesenchymal stem cells
10/12/2011	EP2374880A1 Method for inhibiting proliferation of cells

1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 870